Plasma Exchange

Subscribe to Selected New Research on Plasma Exchange

2242 relevant articles (325 outcomes, 212 trials/studies) found for this Therapy

Description: Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.

Also Known As:

Exchange, Plasma; Exchanges, Plasma; Plasma Exchanges

Relationship Network

Therapy Context: Research Results

Therapeutics: 6127

Biological Therapy: 935

Blood Transfusion: 8851

Plasma Exchange: 2242

Experts

1.	George, James N: 5 articles (02/2008 - 03/2003)
2.	Pagnoux, Christian: 4 articles (04/2007 - 04/2003)
3.	Chevret, S: 4 articles (01/2002 - 01/2001)
4.	De Silvestro, G: 3 articles (08/2008 - 07/2000)
5.	Marson, P: 3 articles (08/2008 - 07/2000)
6.	Ito, Shuichi: 3 articles (04/2008 - 01/2004)
7.	Yokota, Shumpei: 3 articles (04/2008 - 01/2004)
8.	Vesely, Sara K: 3 articles (02/2008 - 03/2003)
9.	Mori, Masaaki: 3 articles (02/2008 - 01/2004)
10.	Duvall, Deanna: 3 articles (02/2008 - 03/2003)

Related Diseases

1.	Thrombotic Thrombocytopenic Purpura 01/01/2002 - "The clinical course of thrombotic thrombocytopenic purpura has dramatically improved after the introduction of plasma-based therapy, including plasma exchange and plasma infusion. " 04/01/1991 - "This study supports the hypothesis that plasma exchange has significantly improved the prognosis of patients with thrombotic thrombocytopenic purpura. " 06/01/1989 - "Laboratory data then were conclusive for a thrombotic thrombocytopenic purpura (Moschcowitz's disease) and therefore the patient was subjected to plasma exchange during seven days: this measure induced rapid and full clinical and laboratory remission. " 08/08/1991 - "Plasma exchange is more effective than plasma infusion in the treatment of thrombotic thrombocytopenic purpura." 12/01/1989 - "[Thrombotic thrombocytopenic purpura which was effectively treated by plasma exchange therapy--involvement of vWF and endothelial cell injury]" Order ALL the reference details at left...
2.	Syndrome 09/01/2008 - "Whilst randomised control trials are undoubtedly the best way to demonstrate whether plasma exchange or infusion alone is the best first-line treatment for patients with atypical haemolytic uremic syndrome (aHUS), individual case reports can provide valuable information. " 12/01/1999 - "The most recent approach is aggressive plasma exchange (PE) employing cryopoor plasma for replacement, based on the pathogenetic relevance given to exceedingly large Von Willebrand (VWF) multimers in the determination of the syndrome with normalization during remission. " 10/01/1992 - "A 19-year-old man with Guillain-Barré syndrome (GBS), who had been bedridden, dramatically improved after plasma exchange despite electrophysiological evidence of severe axonal damage. " 12/04/1990 - "Plasma exchange has proven to be effective in diseases of established or presumed autoimmune etiology as well as in hyperviscosity syndromes and some rare metabolic disorders. " 07/01/1990 - "Emergency plasma exchange produced marked improvement in the clinical manifestations of hyperviscosity syndrome. " Order ALL the reference details at left...
3.	Myasthenia Gravis 01/01/2002 - "On the other hand,experience from many non-randomised studies suggests that plasma exchange is beneficial in myasthenia gravis. " 05/01/1981 - "Antibody-negative acquired myasthenia gravis: successful therapy with plasma exchange." 08/01/1993 - "Immunoadsorption plasmapheresis is an effective treatment for severe generalised myasthenia gravis of childhood and is superior to plasma exchange with respect to safety." 04/01/1991 - "A short plasma exchange protocol is effective in severe myasthenia gravis." 07/01/1984 - "These cases illustrate that long-term plasma exchange is feasible and effective in selected exchange-dependent patients with myasthenia gravis." Order ALL the reference details at left...
4.	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/01/1995 - "We report 7 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who showed significant clinical improvement by plasma exchange (PE). " 05/01/1985 - "Results in this unselected, consecutive patient trial suggest a temporal relationship between plasma exchange and clinical improvement in some patients with progressive CIDP." 01/01/1982 - "It is too early to draw any conclusion from these studies other than that the double-blind study employed here is feasible and should provide information on the efficacy of plasma exchange in CIDP if its effect is prompt and large. " 01/01/2004 - "OBJECTIVES: To evaluate the efficacy of plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. " 07/01/1989 - "[Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy]" Order ALL the reference details at left...
5.	Glomerulonephritis 11/27/1981 - "The combination of plasma exchange and immunosuppression appears to result in considerable improvement of therapeutic measures in rapidly progressive glomerulonephritis. " 11/01/1997 - "The present study was carried out to examine the efficacy of plasma exchange in patients with rapidly progressive glomerulonephritis (RPGN). " 01/01/1988 - "Thus, in non-autoantibody induced rapidly progressive glomerulonephritis, kidney function could be improved substantially by immunosuppressive therapy, but an advantage of supplementary plasma exchange could not be shown." 07/01/1986 - "Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. " 07/01/1983 - "Improved outcome in rapidly progressive glomerulonephritis by plasma exchange treatment." Order ALL the reference details at left...

Related Drugs and Biologics

1.	thymidine 5'-triphosphate (TTP)
2.	Immunoglobulins (Immunoglobulin)
3.	Intravenous Immunoglobulins (IVIG)
4.	Adrenal Cortex Hormones (Corticosteroids)
5.	Cyclophosphamide (Cytoxan)
6.	Steroids
7.	Prednisone (Sone)
8.	Methylprednisolone
9.	rituximab (Mabthera)
10.	Antibodies

Related Therapies and Procedures

1.	Plasmapheresis
2.	Renal Dialysis (Hemodialysis)
3.	Splenectomy
4.	Drug Therapy (Chemotherapy)
5.	Blood Component Removal (Apheresis)

Best Treatments:
Research Summary Report
on Thrombotic Thrombocytopenic Purpura

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 111 Outcomes
Top 200 Key Drugs and Biologics
Top 45 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>